Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v6-EN
Language English English
Date Updated 2019-04-19 2019-04-15
Drug Identification Number 00807788 00807788
Brand name BLEPHAMIDE OPHT SUSPENSION BLEPHAMIDE OPHT SUSPENSION
Common or Proper name Sulfacetamide-Prednisolone Sulfacetamide-Prednisolone
Company Name ALLERGAN INC ALLERGAN INC
Ingredients PREDNISOLONE ACETATE SULFACETAMIDE SODIUM PREDNISOLONE ACETATE SULFACETAMIDE SODIUM
Strength(s) 0.2% 10% 0.2% 10%
Dosage form(s) DROPS DROPS
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10ml 10ml
ATC code S01CA S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-03-04 2019-03-04
Actual start date 2019-03-04 2019-03-04
Estimated end date 2019-04-16 2019-04-16
Actual end date 2019-04-18
Shortage status Resolved Actual shortage
Company comments
Health Canada comments